U.S. Water Utilities Stock News

Illumina (ILMN) opened 2026 with Q1 revenue of US$1,091 million and basic EPS of US$0.88, setting the tone for how the year is starting to shape up after its recent return to profitability. Over the past five quarters, revenue has moved within a tight band between US$1,041 million and US$1,159 million, while quarterly basic EPS has ranged from US$0.82 to US$2.18. This gives investors a clearer view of how earnings power has translated from the top line. With trailing 12 month net income back...

Without a specific news headline driving Hancock Whitney (HWC) today, the stock still draws attention from investors who are reviewing recent returns, profitability figures, and its current share price of US$67.17. See our latest analysis for Hancock Whitney. Recent trading has been relatively steady, with a 1 month share price return of 4.77% and a year to date share price return of 4.20%, set against a 1 year total shareholder return of 28.01% that builds on a 109.91% total shareholder...

Roku (ROKU) has just opened 2026 earnings season with Q1 results that build on a clear turnaround in the numbers, capped by Q4 2025 revenue of about US$1.4b and basic EPS of US$0.54. Over the past year, quarterly revenue has moved from US$1,201.0m in Q4 2024 to US$1,394.9m in Q4 2025, while basic EPS shifted from a loss of US$0.24 to a profit of US$0.54. This sets up a story in which improving profitability sits at the center of the earnings debate, with margins in focus as investors weigh...

In late April 2026, HP Inc. expanded its HyperX gaming portfolio with the Clutch Talon customizable controller, Cloud Stinger 3 headsets starting at US$49.99, and a full launch of its enhanced NGENUITY personalization software. This push deeper into gaming peripherals and software suggests HP is working to build a broader ecosystem around player customization and cross-platform performance. We’ll now examine how HP’s push into a more customizable HyperX ecosystem may influence the company’s...

If you are wondering whether Cognizant Technology Solutions is attractively priced right now, the key is understanding what the current share price implies about its future. The stock last closed at US$52.43, after returns of a 4.9% decline over 7 days, 14.4% decline over 30 days, 35.5% decline year to date, 31.3% decline over 1 year, 12.9% decline over 3 years, and 24.1% decline over 5 years. Recent share price moves sit against a broader backdrop of ongoing interest in large IT services...

In late April 2026, Joby Aviation completed the first-ever point-to-point eVTOL air taxi demonstration flights across New York City using existing heliports, showcasing quiet, zero operating emissions journeys between JFK Airport, Lower Manhattan, and Midtown in under 10 minutes. By flying real-world urban routes within complex FAA-controlled airspace, Joby provided a practical proof-of-concept for how its aircraft could integrate into established heliport networks and broader city...

If you are wondering whether Bandwidth, at a last close of US$44.86, still offers value after a strong run, the key question is how its current price lines up with its underlying fundamentals. The stock has recorded returns of 86.0% over 7 days, 150.2% over 30 days, 215.5% year to date and 259.2% over 1 year, while the 5 year return sits at a 64.3% decline and the 3 year return is 289.7%. Recent share price moves have come alongside ongoing interest in cloud based communications and software...

For investors considering whether Guardant Health at around US$87.60 represents fair value or a potential opportunity, this article examines what that price may indicate about the stock. The share price is US$87.60 after a 1.5% decline over the past week and a 3.9% decline over the past month. It is still up 87.0% over the past year and 270.4% over three years, while a 35.3% decline over five years provides additional context. Recent news about Guardant Health has highlighted its role in...

IDEAYA Biosciences (IDYA) is back in focus after the FDA agreed to review its New Drug Application for darovasertib plus crizotinib in first line metastatic uveal melanoma under a Real-Time Oncology Review program. See our latest analysis for IDEAYA Biosciences. Even with the FDA review decision and recent positive Phase 2/3 data, IDEAYA Biosciences’ share price has pulled back, with a 30 day share price return of a 13.21% decline and a year to date share price return of a 16.72% decline,...

Wondering whether Sportradar Group's current share price reflects its true worth, or if the market is mispricing the story. The stock last closed at US$13.26, with returns of 0.2% over 7 days, a 20.3% decline over 30 days, and year to date and 1 year returns of 43.1% and 44.1% declines, while the 3 year return sits at 1.8%. Recent coverage has focused on Sportradar Group as a listed sports data and technology provider, with attention on how it is positioned in the wider sports betting and...

Why TriNet Group is on investors’ radar today TriNet Group (TNET) has drawn attention after a period of mixed share performance, with a strong month and past week set against weaker returns over the past 3 months and year. See our latest analysis for TriNet Group. At a share price of US$44.47, TriNet Group’s recent 24% 30 day share price return contrasts with a 27% 90 day share price decline and a 44% 1 year total shareholder return loss, suggesting fading longer term momentum despite the...

Wondering if American Electric Power Company at about US$136.91 is offering fair value or if you might be paying over the odds? This article breaks down what the current pricing could mean for you. The stock last closed at US$136.91, with returns of 1.6% over 7 days, 4.0% over 30 days, 18.2% year to date, 31.4% over 1 year, 66.4% over 3 years, and 86.7% over 5 years. This provides useful context before assessing any valuation metrics. Recent trading interest has been shaped by ongoing...

APA stock performance snapshot APA (APA) has drawn fresh attention after recent trading, with the share price closing at US$40.13. The stock shows mixed short term moves, including a 1.5% decline over the past day and a 6.4% gain over the past week. See our latest analysis for APA. The recent 6.4% 7 day share price return, alongside a 90 day share price return of 51.9% and a 1 year total shareholder return of 154.0%, points to strong momentum despite short term pullbacks. If APA’s move has...

First Industrial Realty Trust expanded its board and appointed Frank E. Schmitz as an independent director. The move follows a recent activist investor campaign focused on board composition and governance. The appointment comes in a contested board setting, signaling a response to shareholder pressure. For investors watching NYSE:FR, this board change occurs at a time when the stock is trading at $62.14 and has returned 31.2% over the past year and 44.6% over the past five years. Those...

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...

In late April 2026, TTM Technologies reported record first-quarter 2026 results with net sales of US$845.98 million and net income of US$49.99 million, and issued second-quarter guidance calling for net sales between US$930 million and US$970 million. The company highlighted that robust demand tied to artificial intelligence data center buildouts and defense-related programs now underpins the majority of its revenue base, supporting record non-GAAP earnings and higher capital investment...

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...

Q1 results and digital-first push in focus for OFG Bancorp (OFG) OFG Bancorp (OFG) has been in focus after first quarter results topped Wall Street expectations, with management pointing to ongoing loan growth, steady credit performance, and disciplined expense management. See our latest analysis for OFG Bancorp. The share price has gained 11.3% over the past month and 13.5% over the past quarter. The 1 year total shareholder return of 13.8% and 3 year total shareholder return, which is about...

Beyond Meat recently expanded its retail footprint by rolling out Beyond Chicken Pieces Spicy Buffalo to more than 2,000 Kroger stores across the U.S., while the U.S. Army signaled interest in plant-based proteins for future field rations. These developments highlight how product innovation and potential government demand could interact with Beyond Meat’s existing efforts to refine its portfolio and operations. We’ll now examine how the U.S. Army’s interest in plant-based protein could...

Recent trading in PHINIA (PHIN) has drawn attention after the stock’s 1 year total return reached 80.31%, prompting investors to look more closely at its current valuation, profitability, and growth profile. See our latest analysis for PHINIA. At a share price of $74.02, PHINIA’s recent 1 month share price return of 6.32% and year to date share price return of 14.49% sit alongside a 1 year total shareholder return of 80.31%. Investors are now weighing this momentum against its valuation and...

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...

If you are wondering whether Arrowhead Pharmaceuticals' current share price lines up with its fundamentals, this article walks through the key valuation angles that matter to you. The stock last closed at US$74.81, with returns of 1.2% over 7 days, 18.9% over 30 days, 10.4% year to date, 418.8% over 1 year and 80.8% over 3 years, compared with 12.7% over 5 years. Recent market focus around Arrowhead Pharmaceuticals has centred on its position in the biopharmaceutical space and ongoing...

Operational momentum behind recent price move Hecla Mining (HL) recently drew investor attention after a very large year over year jump in earnings per share and a 79.5% rise in quarterly revenue, alongside higher next quarter EPS estimates. See our latest analysis for Hecla Mining. Despite the latest 0.22% 1-day share price return and recent short-term weakness, Hecla Mining’s very large 1-year total shareholder return of 298.47% signals that momentum has been building over a longer...